Focal therapy for localized prostate cancer - Current status

Shrikanth Atluri, Ali Mouzannar, Vivek Venkatramani, Dipen J. Parekh, Bruno Nahar

Research output: Contribution to journalReview articlepeer-review


Focal therapy (FT) has recently gained popularity for the treatment of localized prostate cancer (PCa). FT achieves cancer control by targeting the lesions or the regions of the cancer and avoids damage to the surrounding tissues thus minimizing side effects which are common to the radical treatment, such as urinary continence and sexual function, and bowel-related side effects. Various ablative methods are used to deliver energy to the cancerous tissue. We review the different modalities of treatment and the current state of FT for PCa.

Original languageEnglish (US)
Pages (from-to)7-14
Number of pages8
JournalIndian Journal of Urology
Issue number1
StatePublished - Jan 1 2022
Externally publishedYes

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Focal therapy for localized prostate cancer - Current status'. Together they form a unique fingerprint.

Cite this